6bd544b637b85920847c667dc.mPU4yS5xmMBTqvB4cZZvKZxpNNhB09XP26kll0YqzGw.z40JhmoD7q88yLlVQ9MrX6Q9cZkm5a32ut1MzRIYoQagxnyjZQT8n2Cdhw
19/11 IXICO Plc Announces New Release Of IXI Platform And Advanced Biomarker Partnerships CI
19/11 Ixico Partners with Neuropacs, ZRO Imaging to Expand Neurological Imaging Platform MT
17/11 IXICO Plc Develops New AI Tool Supporting Radiologists To Detect Vascular Dysfunction In Alzheimer?s Disease CI
02/11 IXICO plc Wins £2.7 Million Phase 3 Contract in Huntington's Disease CI
29/10 IXICO Plc Presents Research On Novel Methods To Reduce Unwanted Variability In Huntington?s Disease Biomarker Data CI
22/10 Ixico Wins New Contract, Extension Totaling GBP1.5 Million MT
22/10 IXICO plc Announces Two Contracts In Alzheimer?s Disease Worth £1.5 Million CI
21/10 Ixico stock rises as forecasts full-year revenue and earnings beat AN
20/10 WINNERS & LOSERS: Ixico beats expectations; Shearwater wins deal AN
20/10 IXICO plc Raises Earnings Guidance for the Year Ending 30 September 2026 CI
02/10 IXICO plc Presents Advancements In Neuroimaging For Parkinson?s Disease At European Radiology Conference CI
13/07 Ixico notes ending of Huntington's disease programmes AN
13/07 WINNERS & LOSERS: Ixico lower order book; Pennant sees revenue jump AN
13/07 Ixico Says Two Huntington's Disease Programs Discontinued by Sponsors MT
07/07 IXICO plc Provides Earnings Guidance for the Year Ending 30 September 2026 CI
07/07 Ixico ups guidance; Steppe Cement revenue up AN
08/06 Ixico plc Announces Appointments on Scientific Advisory Board CI
08/06 Ixico Has Enters into A Research Collaboration with the Paris Brain Institute CI
22/05 IXICO plc, H1 2026 Earnings Call, May 19, 2026
21/05 BTG to beat expectations; Sabre backs outlook AN
21/05 Ixico Bags New Contract, Extension Worth GBP1.3 Million MT
21/05 Ixico announces contract win & extension with total value of £1.3 million over 2 years RE
21/05 Ixico plc Announces Contract Win and Extension CI
20/05 Ixico reaffirms growth guidance as half-year revenue rises AN
19/05 Ixico remains focused on delivering on guidance of 15% revenue growth for full year RE

Become a member to access more news

New member
No results match your criteria